Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 15-Nov-24 4:05 PM View:  | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 14-Nov-24 | Option Sale | 17,500 | $53.93 | $943,775.00 | (7%) 238.44K to 220.94K | |
| 15-Nov-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 14-Nov-24 | Option Exercise | 17,500 | $3.02 | $52,850.00 | 8% 220.94K to 238.44K | |
| 15-Nov-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 13-Nov-24 | Option Sale | 17,500 | $55.57 | $972,475.00 | (7%) 238.44K to 220.94K | |
| 15-Nov-24 4:05 PM View: | McLaughlin Kevin F Director | Aastrom Biosciences, Inc. (VCEL) | 13-Nov-24 | Option Sale | 7,000 | $55.54 | $388,780.00 | (37%) 18.9K to 11.9K | |
| 15-Nov-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 13-Nov-24 | Option Exercise | 17,500 | $3.02 | $52,850.00 | 8% 220.94K to 238.44K | |
| 15-Nov-24 4:05 PM View: | McLaughlin Kevin F Director | Aastrom Biosciences, Inc. (VCEL) | 13-Nov-24 | Option Exercise | 7,000 | $3.74 | $26,180.00 | 59% 11.9K to 18.9K | |
| 04-Oct-24 4:06 PM View: | Gilman Steven C Director | Aastrom Biosciences, Inc. (VCEL) | 02-Oct-24 | Option Exercise | 5,833 | $13.05 | $76,120.60 | 53% 11.0K to 16.83K | |
| 04-Oct-24 4:06 PM View: | Gilman Steven C Director | Aastrom Biosciences, Inc. (VCEL) | 02-Oct-24 | Planned Option Sale | 5,833 | $40.35 | $235,362.00 | (35%) 16.83K to 11.0K | |
| 20-Sep-24 4:05 PM View: | Gilman Steven C Director | Aastrom Biosciences, Inc. (VCEL) | 18-Sep-24 | Option Exercise | 5,834 | $13.05 | $76,133.70 | 53% 11.0K to 16.83K | |
| 20-Sep-24 4:05 PM View: | Gilman Steven C Director | Aastrom Biosciences, Inc. (VCEL) | 18-Sep-24 | Planned Option Sale | 5,834 | $45.54 | $265,680.00 | (35%) 16.83K to 11.0K | |
| 13-Sep-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 12-Sep-24 | Option Sale | 17,500 | $43.90 | $768,250.00 | (7%) 238.44K to 220.94K | |
| 13-Sep-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 12-Sep-24 | Option Exercise | 17,500 | $3.02 | $52,850.00 | 8% 220.94K to 238.44K | |
| 13-Sep-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 11-Sep-24 | Option Exercise | 17,500 | $3.02 | $52,850.00 | 8% 220.94K to 238.44K | |
| 13-Sep-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 11-Sep-24 | Option Sale | 17,500 | $43.37 | $758,975.00 | (7%) 238.44K to 220.94K | |
| 05-Sep-24 4:06 PM View: | Gilman Steven C Director | Aastrom Biosciences, Inc. (VCEL) | 04-Sep-24 | Option Exercise | 5,000 | $3.74 | $18,700.00 | 45% 11.0K to 16.0K | |
| 05-Sep-24 4:06 PM View: | Gilman Steven C Director | Aastrom Biosciences, Inc. (VCEL) | 04-Sep-24 | Planned Option Sale | 5,000 | $48.58 | $242,900.00 | (31%) 16.0K to 11.0K | |
| 05-Sep-24 4:05 PM View: | Hopper Jonathan Mark Chief Medical Officer | Aastrom Biosciences, Inc. (VCEL) | 03-Sep-24 | Planned Option Sale | 10,000 | $49.83 | $498,300.00 | (15%) 68.23K to 58.23K | |
| 05-Sep-24 4:05 PM View: | Hopper Jonathan Mark Chief Medical Officer | Aastrom Biosciences, Inc. (VCEL) | 03-Sep-24 | Option Exercise | 10,000 | $10.95 | $109,500.00 | 17% 58.23K to 68.23K | |
| 16-Aug-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 15-Aug-24 | Option Sale | 17,500 | $46.24 | $809,200.00 | (7%) 238.44K to 220.94K | |
| 16-Aug-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 15-Aug-24 | Option Exercise | 17,500 | $3.02 | $52,850.00 | 8% 220.94K to 238.44K | |
| 16-Aug-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 14-Aug-24 | Option Sale | 17,500 | $45.17 | $790,475.00 | (7%) 238.44K to 220.94K | |
| 16-Aug-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 14-Aug-24 | Option Exercise | 17,500 | $3.02 | $52,850.00 | 8% 220.94K to 238.44K | |
| 09-Aug-24 4:05 PM View: | McLaughlin Kevin F Director | Aastrom Biosciences, Inc. (VCEL) | 07-Aug-24 | Option Exercise | 7,000 | $3.74 | $26,180.00 | 59% 11.9K to 18.9K | |
| 09-Aug-24 4:05 PM View: | McLaughlin Kevin F Director | Aastrom Biosciences, Inc. (VCEL) | 07-Aug-24 | Option Sale | 7,000 | $45.94 | $321,580.00 | (37%) 18.9K to 11.9K | |
| 19-Jul-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 18-Jul-24 | Option Exercise | 17,500 | $3.02 | $52,850.00 | 8% 220.94K to 238.44K | |
| 19-Jul-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 18-Jul-24 | Option Sale | 17,500 | $51.40 | $899,500.00 | (7%) 238.44K to 220.94K | |
| 19-Jul-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 17-Jul-24 | Option Exercise | 17,500 | $3.02 | $52,850.00 | 8% 220.94K to 238.44K | |
| 19-Jul-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 17-Jul-24 | Option Sale | 17,500 | $51.55 | $902,125.00 | (7%) 238.44K to 220.94K | |
| 18-Jul-24 4:05 PM View: | Flynn Sean C. Chief Legal Officer | Aastrom Biosciences, Inc. (VCEL) | 16-Jul-24 | Option Sale | 15,000 | $52.18 | $782,700.00 | (95%) 15.71K to 0.71K | |
| 18-Jul-24 4:05 PM View: | Flynn Sean C. Chief Legal Officer | Aastrom Biosciences, Inc. (VCEL) | 16-Jul-24 | Option Exercise | 15,000 | $16.25 | $243,750.00 | 2122% 0.71K to 15.71K | |
| 16-Jul-24 4:05 PM View: | Mara Joseph Anthony Jr Chief Financial Officer | Aastrom Biosciences, Inc. (VCEL) | 12-Jul-24 | Private Sale | 5,000 | $50.00 | $250,000.00 | (26%) 19.44K to 14.44K | |
| 09-Jul-24 4:05 PM View: | Siegal Jonathan Principal Accounting Officer | Aastrom Biosciences, Inc. (VCEL) | 05-Jul-24 | Private Sale | 545 | $45.00 | $24,525.00 | (35%) 1.58K to 1.03K | |
| 24-Jun-24 6:21 PM View: | Flynn Sean C. Chief Legal Officer | Aastrom Biosciences, Inc. (VCEL) | 24-Jun-24 | Option Exercise | 1,474 | $16.25 | $23,952.50 | 303% 0.49K to 1.96K | |
| 24-Jun-24 6:21 PM View: | Flynn Sean C. Chief Legal Officer | Aastrom Biosciences, Inc. (VCEL) | 24-Jun-24 | Option Sale | 1,474 | $45.84 | $67,568.20 | (75%) 1.96K to 0.49K | |
| 24-Jun-24 6:21 PM View: | Flynn Sean C. Chief Legal Officer | Aastrom Biosciences, Inc. (VCEL) | 21-Jun-24 | Option Exercise | 6,772 | $16.25 | $110,045.00 | 1391% 0.49K to 7.26K | |
| 24-Jun-24 6:21 PM View: | Flynn Sean C. Chief Legal Officer | Aastrom Biosciences, Inc. (VCEL) | 21-Jun-24 | Option Sale | 6,772 | $45.02 | $304,875.00 | (93%) 7.26K to 0.49K | |
| 24-Jun-24 6:21 PM View: | Flynn Sean C. Chief Legal Officer | Aastrom Biosciences, Inc. (VCEL) | 20-Jun-24 | Option Sale | 6,754 | $45.04 | $304,200.00 | (93%) 7.24K to 0.49K | |
| 24-Jun-24 6:21 PM View: | Flynn Sean C. Chief Legal Officer | Aastrom Biosciences, Inc. (VCEL) | 20-Jun-24 | Option Exercise | 6,754 | $16.25 | $109,752.00 | 1387% 0.49K to 7.24K | |
| 14-Jun-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 13-Jun-24 | Option Exercise | 17,500 | $3.02 | $52,850.00 | 8% 220.75K to 238.25K | |
| 14-Jun-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 13-Jun-24 | Option Sale | 17,500 | $43.10 | $754,250.00 | (7%) 238.25K to 220.75K | |
| 14-Jun-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 12-Jun-24 | Option Exercise | 17,500 | $3.02 | $52,850.00 | 8% 220.75K to 238.25K | |
| 14-Jun-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 12-Jun-24 | Option Sale | 17,500 | $44.12 | $772,100.00 | (7%) 238.25K to 220.75K | |
| 05-Jun-24 4:05 PM View: | Wright Lisa Director | Aastrom Biosciences, Inc. (VCEL) | 03-Jun-24 | Option Exercise | 434 | -- | -- | 5% 9.02K to 9.45K | |
| 21-May-24 4:07 PM View: | Hopper Jonathan Mark Chief Medical Officer | Aastrom Biosciences, Inc. (VCEL) | 20-May-24 | Option Exercise | 10,000 | $10.95 | $109,500.00 | 17% 58.12K to 68.12K | |
| 21-May-24 4:07 PM View: | Hopper Jonathan Mark Chief Medical Officer | Aastrom Biosciences, Inc. (VCEL) | 20-May-24 | Planned Option Sale | 10,000 | $49.99 | $499,900.00 | (15%) 68.12K to 58.12K | |
| 21-May-24 4:05 PM View: | Halpin Michael Chief Operating Officer | Aastrom Biosciences, Inc. (VCEL) | 17-May-24 | Option Exercise | 5,195 | $5.39 | $28,017.30 | 477% 1.09K to 6.28K | |
| 17-May-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 16-May-24 | Option Exercise | 17,500 | $3.02 | $52,850.00 | 8% 220.75K to 238.25K | |
| 17-May-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 16-May-24 | Option Sale | 17,500 | $47.85 | $837,375.00 | (7%) 238.25K to 220.75K | |
| 17-May-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 15-May-24 | Option Exercise | 17,500 | $3.02 | $52,850.00 | 8% 220.75K to 238.25K | |
| 17-May-24 4:05 PM View: | Colangelo Dominick President and CEO Director | Aastrom Biosciences, Inc. (VCEL) | 15-May-24 | Option Sale | 17,500 | $49.67 | $869,225.00 | (7%) 238.25K to 220.75K |
